Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Why Cholesterol and Alzheimer’s Could Drive Eli Lilly Shares Much Higher
Why Cholesterol and Alzheimer’s Could Drive Eli Lilly Shares Much Higher
Why Cholesterol and Alzheimer’s Could Drive Eli Lilly Shares Much Higher
Submitted by
admin
on October 9, 2015 - 3:56pm
Source:
24/7 Wall St
News Tags:
Eli Lilly
solanezumab
evacetrapib
Alzheimer's disease
Headline:
Why Cholesterol and Alzheimer’s Could Drive Eli Lilly Shares Much Higher
Do Not Allow Advertisers to Use My Personal information
